Middle East, North Africa, Afghanistan & Pakistan vs Zimbabwe: Access to anti-retroviral drugs, male
Middle East, North Africa, Afghanistan & Pakistan
25.6%
in 2024
Zimbabwe
89.0%
in 2024
Middle East, North Africa, Afghanistan & Pakistan rank
17th
Zimbabwe rank
17th
Access to anti-retroviral drugs, male over time
- Middle East, North Africa, Afghanistan & Pakistan
- Zimbabwe
How they compare
Zimbabwe currently reports 89.0% against 25.6% in Middle East, North Africa, Afghanistan & Pakistan, a difference of 63.4%.
That makes Zimbabwe's figure about 3.5 times Middle East, North Africa, Afghanistan & Pakistan's.
The two have swapped places 1 time across 25 shared years of data; in 2000 it was Middle East, North Africa, Afghanistan & Pakistan ahead.
Middle East, North Africa, Afghanistan & Pakistan ranks 17th and Zimbabwe ranks 17th of 19 groups.
Across the 3 decades both report, Middle East, North Africa, Afghanistan & Pakistan averaged higher in 1 and Zimbabwe in 2.
Head to head by decade
| Decade | Middle East, North Africa, Afghanistan & Pakistan | Zimbabwe | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 6.1% | 4.1% | 2.0% | Middle East, North Africa, Afghanistan & Pakistan |
| 2010s | 12.2% | 52.9% | 40.7% | Zimbabwe |
| 2020s | 21.9% | 88.4% | 66.5% | Zimbabwe |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Middle East, North Africa, Afghanistan & Pakistan or Zimbabwe?
- Zimbabwe, at 89.0% against 25.6% in Middle East, North Africa, Afghanistan & Pakistan as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Middle East, North Africa, Afghanistan & Pakistan and Zimbabwe?
- 63.4%, with Zimbabwe ahead.
- How many years of comparable data are there for Middle East, North Africa, Afghanistan & Pakistan and Zimbabwe?
- 25 years are reported by both, from 2000 to 2024.
- How do Middle East, North Africa, Afghanistan & Pakistan and Zimbabwe rank globally for access to anti-retroviral drugs, male?
- Middle East, North Africa, Afghanistan & Pakistan ranks 17th and Zimbabwe ranks 17th of 19 groups.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.